|
Transcription Factor Brn-3
|
D050818 |
[A family of mammalian POU domain factors that are expressed predominately in NEURONS.
] |
|
Transcription Factor Brn-3A
|
D050819 |
[A POU domain factor that activates GENETIC TRANSCRIPTION of GENES encoding NEUROFILAMENT PROTEINS; alpha internexin; SYNAPTOSOMAL-ASSOCIATED PROTEIN 25; and BCL-2 PROTO-ONCOGENE PROTEINS.
] |
|
saringosterol
|
C442582 |
|
|
Pregnadienetriols
|
D011246 |
[Doubly unsaturated pregnane derivatives substituted with three hydroxy groups anywhere within the ring structure or side chains.
] |
|
Pregnancy
|
D011247 |
[The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.
] |
|
Pregnancy Complications
|
D011248 |
[Conditions or pathological processes associated with pregnancy. They can occur during or after pregnancy, and range from minor discomforts to serious diseases that require medical interventions. They include diseases in pregnant females, and pregnancies in females with diseases.
] |
|
Pregnancy Complications, Cardiovascular
|
D011249 |
[The co-occurrence of pregnancy and a cardiovascular disease. The disease may precede or follow FERTILIZATION and it may or may not have a deleterious effect on the pregnant woman or FETUS.
] |
|
Prednisone
|
D011241 |
[A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
] |
|
Preferred Provider Organizations
|
D011243 |
[Arrangements negotiated between a third-party payer (often a self-insured company or union trust fund) and a group of health-care providers (hospitals and physicians) who furnish services at lower than usual fees, and, in return, receive prompt payment and an expectation of an increased volume of patients.
] |
|
Pregnadienediols
|
D011244 |
[Doubly unsaturated pregnane derivatives with two hydroxy groups substituted anywhere on the rings or side chains.
] |
|
Pregnadienes
|
D011245 |
[Pregnane derivatives containing two double bonds anywhere within the ring structures.
] |
|
Polyubiquitin
|
D025821 |
[An oligomer formed from the repetitive linking of the C-terminal glycine of one UBIQUITIN molecule via an isopeptide bond to a lysine residue on a second ubiquitin molecule. It is structurally distinct from UBIQUITIN C, which is a single protein containing a tandemly arrayed ubiquitin peptide sequence.
] |
|
Ubiquitin C
|
D025822 |
[A single protein comprised of tandem repeats of the UBIQUITIN 78-amino acid sequence. It is a product of the polyubiquitin gene which contains multiple copies of the ubiquitin coding sequence. Proteolytic processing of ubiquitin C results in the formation of individual ubiquitin molecules. This protein is distinct from POLYUBIQUITIN, which is a protein formed through isopeptide linkage of multiple ubiquitin species.
] |
|
alpha,beta-diformamido-beta-(5'-phosphoribosylamino)acrylamide
|
C021010 |
|
|
dihydrostreptomycin 6-phosphate
|
C021011 |
|
|
17 alpha,20 beta-dihydroxypregn-4-en-3-one
|
C021012 |
|
|
N(6),N(6)-dimethyladenosine
|
C021013 |
|
|
angiotensin II, 1-N(4)-dimethyl-Asp-
|
C021014 |
|
|
1-stearoyl-2-linoleoylphosphatidylcholine
|
C060612 |
|
|
2,4-dinitrophenyl-6-N-aminocaproylphosphatidylethanolamine
|
C021015 |
|
